Exor N.V.: CLARIVATE PLC (CLVT): Quarterly 13F Position History
As of Q1 2026, Exor N.V. reported 67,294,884 shares of CLARIVATE PLC (CLVT), worth $170.3M and representing 3.2% of its 13F equity book. The position first appeared in Q4 2022 and has been disclosed across 14 13F-HR filings in Pactolio's tracked window.
- 67,294,884Shares Held (Latest Filing)
- $170.3MReported Market Value (Latest Filing)
- 3.2%Portfolio Weight (% of 13F Equity Book)
- 0Quarter-over-Quarter Share Change
- -$54.5MQuarter-over-Quarter Value Change
- 67,294,884Peak Reported Shares (Historical)
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 14 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q1 2026 | 67,294,884 | 0 | — | $170.3M | 3.2% | $2.5 |
| Q4 2025 | 67,294,884 | 0 | — | $224.8M | 4.0% | $3.3 |
| Q3 2025 | 67,294,884 | 0 | — | $257.7M | 4.4% | $3.8 |
| Q2 2025 | 67,294,884 | 0 | — | $289.4M | 6.2% | $4.3 |
| Q1 2025 | 67,294,884 | 0 | — | $264.5M | 5.7% | $3.9 |
| Q4 2024 | 67,294,884 | 0 | — | $341.9M | 7.6% | $5.1 |
| Q3 2024 | 67,294,884 | 0 | — | $477.8M | 8.2% | $7.1 |
| Q2 2024 | 67,294,884 | 0 | — | $382.9M | 8.5% | $5.7 |
| Q1 2024 | 67,294,884 | +1,566,519 | +2.4% | $500.0M | 15.2% | $7.4 |
| Q4 2023 | 65,728,365 | +33,256,346 | +102.4% | $608.6M | 15.8% | $9.3 |
| Q3 2023 | 32,472,019 | 0 | — | $217.9M | 7.3% | $6.7 |
| Q2 2023 | 32,472,019 | 0 | — | $309.5M | 34.2% | $9.5 |
| Q1 2023 | 32,472,019 | +15,806,037 | +94.8% | $304.9M | 100.0% | $9.4 |
| Q4 2022 | 16,665,982 | — | — | $139.0M | 100.0% | $8.3 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares — a quarter-end mark, not the manager's cost basis. See the full methodology document for the normalization rules.
When did Exor N.V. first disclose a CLVT position in 13F-HR filings?
Exor N.V. first reported CLARIVATE PLC (CLVT) on its 13F-HR filing for the period ending 2022-12-31 (Q4 2022). The position has appeared on 14 reported quarters within Pactolio's tracked window.
What was Exor N.V.'s most recent quarter-over-quarter share-count change in CLVT?
Exor N.V. held the same 67,294,884 shares of CLVT between Q4 2025 and Q1 2026 — the reported share count was unchanged quarter-over-quarter.
Does the implied price-per-share represent Exor N.V.'s cost basis in CLVT?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.